Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 1099494
Submitted by lobbyist on: January 20, 2020 08:23:21 AM
Accepted by Registrar on: January 20, 2020 11:17:37 AM

Designated Filer Information

Keon, James J  
4100 Yonge Street Suite 501  
Toronto, ON, M2P 2B5
 416-223-2333
Canada  

Organization Information

Canadian Generic Pharmaceutical Association (CGPA)  
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.
4100 Yonge Street Suite 501  
Toronto, BC, M2P 2B5
 416-223-2333
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

January 20, 2020  
July 20, 2020  

Organization's In-House Lobbyists

 



Name: Connell, Jeff
 
January 20, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement and the USMCA. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Payment of distribution fees by the government. Promoting greater utilization of generic prescription medicines. Price increase policy. Scope of listings. National Pharmacare initiative.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health January 20, 2020
Staff of Minister Singh, Jasmyn Minister of Health January 20, 2020
Public Agency Health January 20, 2020

Name: Cox, Jody
 
January 20, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Developing a regulatory pathway for biosimilars. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement and the USMCA.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health January 20, 2020
Staff of Minister Singh, Jasmyn Minister of Health January 20, 2020
Public Agency Health January 20, 2020

Name: Keon, James
 
January 20, 2020  

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement and the USMCA. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Payment of distribution fees by the government. Promoting greater utilization of generic prescription medicines. Price increase policy. Scope of listings. National Pharmacare initiative.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health January 20, 2020
Staff of Minister Singh, Jasmyn Minister of Health January 20, 2020
Public Agency Health January 20, 2020